Critical Comparison: Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) versus BioSig Technologies (NASDAQ:BSGM)

Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Profitability

This table compares Pheton Holdings Ltd Class A Ordinary Shares and BioSig Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A
BioSig Technologies	-44,832.50%	N/A	-776.49%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Pheton Holdings Ltd Class A Ordinary Shares and BioSig Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton Holdings Ltd Class A Ordinary Shares	0	0	0	0	0.00
BioSig Technologies	0	0	1	0	3.00

BioSig Technologies has a consensus target price of $2.75, indicating a potential upside of 400.00%. Given BioSig Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe BioSig Technologies is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.

Institutional and Insider Ownership

7.2% of BioSig Technologies shares are owned by institutional investors. 17.0% of BioSig Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Pheton Holdings Ltd Class A Ordinary Shares and BioSig Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton Holdings Ltd Class A Ordinary Shares	$572,291.00	49.60	N/A	N/A	N/A
BioSig Technologies	$39,000.00	243.06	-$29.04 million	N/A	N/A

Pheton Holdings Ltd Class A Ordinary Shares has higher revenue and earnings than BioSig Technologies.

Summary

BioSig Technologies beats Pheton Holdings Ltd Class A Ordinary Shares on 6 of the 9 factors compared between the two stocks.

About Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.

About BioSig Technologies

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.